1. Complete remission of uveitis: no active disease 3 months after discontinuation of all ophthalmic treatment, 2. Any known contraindications to the vaccine provided according to the manufacturing instructions: (1) Individuals with a history of hypersensitivity to any vaccine component, (2) Individuals whose body temperature exceeds 38.5 degree, (3) Pregnancy. 3. Any other situation that, in the opinion of the investigator, would put the subject at risk due to participation in this study.

1. Complete remission of uveitis: no active disease 3 months after discontinuation of all ophthalmic treatment, 2. Any known contraindications to the vaccine provided according to the manufacturing instructions: (1) Individuals with a history of hypersensitivity to any vaccine component, (2) Individuals whose body temperature exceeds 38.5 degree, (3) Pregnancy. 3. Any other situation that, in the opinion of the investigator, would put the subject at risk due to participation in this study.

1. Complete uveitis remission: Inactive disease for 3 months after discontinuing all treatments for eye disease. 2. Any known vaccine contraindications according to manufactures instructions: (1)Individuals with a history of anaphylaxis to any component of the vaccine, (2)Individuals with a body temperature over 38.5 degree C, (3)Pregnancy. 3. Any other condition which, in the opinion of the Investigator, would put the subject at risk by participation in the protocol.

1. Complete uveitis remission: Inactive disease for 3 months after discontinuing all treatments for eye disease. 2. Any known vaccine contraindications according to manufactures instructions: (1)Individuals with a history of anaphylaxis to any component of the vaccine, (2)Individuals with a body temperature over 38.5 degree C, (3)Pregnancy. 3. Any other condition which, in the opinion of the Investigator, would put the subject at risk by participation in the protocol.